Graphite Bio Inc (GRPH): yup, and the graphite/graphine demand wi...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Graphite Bio Inc (GRPH)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	5387
Posts	51347
Boards Moderated	10
Alias Born	09/19/2006

Re: PennyStalker post# 944

Thursday, 02/23/2017 12:50:38 PM

Thursday, February 23, 2017 12:50:38 PM

yup, and the graphite/graphine demand with Tesla might have something to do with it as well

Business Description

We are involved in the business of identifying nano materials and technologies, securing commercialization rights thereto, financing and commercializing such materials and technologies by introducing them to the relevant markets. Our first two products are graphene electrodes and graphene flakes. Graphene electrodes are suitable for use in energy storage devices, such as batteries and super capacitors, and offer superior performance over conventional and other materials on the market today. Graphene flakes are suitable for use in composite materials in order to improve thermal and mechanical properties.

This info is not to be construed as a solicitation to buy/sell securities. Hdogtx reserves the right to either BUY/SELL shares in a company's stock he mentions.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent GRPH News

Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/08/2024 10:17:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:13:02 PM
Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics • Business Wire • 03/08/2024 10:00:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/05/2024 11:09:26 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:08:01 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 09:11:05 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/13/2024 09:44:23 PM
Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:23:14 PM
Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 02/05/2024 09:57:19 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/05/2024 09:31:56 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 12/26/2023 09:37:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:32:30 PM
Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 12/06/2023 09:57:38 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/15/2023 10:23:53 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/15/2023 01:09:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 01:06:35 PM
LENZ Therapeutics and Graphite Bio Announce Merger Agreement • Business Wire • 11/15/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:08:44 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/13/2023 08:06:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:06:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:04:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 08:07:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/21/2023 09:13:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/21/2023 09:12:02 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/21/2023 09:05:36 PM

More GRPH News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow